Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.

@article{Matsuzaki2001LongtermOO,
  title={Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.},
  author={Akinobu Matsuzaki and Eiichi Ishii and Yoshihisa Nagatoshi and Haruhiko Eguchi and Hirohumi Koga and Fumio Yanai and Hiroko Inada and Kenichi Nibu and Yoshiko Tamai and Kensuke Akiyoshi and Hideki Nakayama and Takuya Hara and Hiroshi Take and Sumio Miyazaki and Jun Okamura},
  journal={International journal of hematology},
  year={2001},
  volume={73 3},
  pages={369-77}
}
We analyzed the long-term outcome and late effects of treatment in 187 patients with childhood acute lymphoblastic leukemia (ALL) diagnosed between 1984 and 1990. Overall survival and event-free survival rates were 68.2% +/- 3.7% and 63.2% +/- 3.6% at 15 years, respectively. Of 55 patients who relapsed after achieving the first complete remission (CR), only… CONTINUE READING